CRISPR Therapeutics (NASDAQ:CRSP) Trading Up 7.1% - Should You Buy? - MarketBeat
9 hours ago • Google News
Crispr Therapeutics AG (CRSP)
US$ 37.531.46%
Price Chart
Key Statistics
Market Cap
$ 4.1B
P/E Ratio
0.00
Revenue (TTM)
$ 37.68M
Volume
1.29M
52W High
$ 63.68
52W Low
$ 30.04
Dividend Yield
0.00%
Beta
1.74
Technicals
50-Day MA
39.3639
200-Day MA
43.136
52 Week High
63.68
52 Week Low
30.04
About CRSP
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISP.
Employees
393
Headquarters
Zug, Switzerland
CEO
Dr. Samarth Kulkarni Ph.D.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg